Triumph Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.36M | Buy |
3,027
+1,850
| +157% | +$1.44M | 0.71% | 27 |
|
2025
Q1 | $972K | Sell |
1,177
-199
| -14% | -$164K | 0.32% | 74 |
|
2024
Q4 | $1.06M | Buy |
1,376
+180
| +15% | +$139K | 0.36% | 57 |
|
2024
Q3 | $1.06M | Buy |
1,196
+531
| +80% | +$470K | 0.38% | 55 |
|
2024
Q2 | $602K | Sell |
665
-101
| -13% | -$91.4K | 0.24% | 101 |
|
2024
Q1 | $582K | Sell |
766
-1,474
| -66% | -$1.12M | 0.24% | 102 |
|
2023
Q4 | $1.31M | Buy |
2,240
+1,392
| +164% | +$811K | 0.55% | 41 |
|
2023
Q3 | $455K | Buy |
848
+10
| +1% | +$5.37K | 0.21% | 110 |
|
2023
Q2 | $393K | Sell |
838
-367
| -30% | -$172K | 0.18% | 116 |
|
2023
Q1 | $414K | Buy |
1,205
+329
| +38% | +$113K | 0.21% | 96 |
|
2022
Q4 | $320K | Buy |
+876
| New | +$320K | 0.17% | 132 |
|
2022
Q2 | – | Sell |
-2,015
| Closed | -$577K | – | 222 |
|
2022
Q1 | $577K | Sell |
2,015
-504
| -20% | -$144K | 0.25% | 102 |
|
2021
Q4 | $696K | Sell |
2,519
-1,111
| -31% | -$307K | 0.3% | 80 |
|
2021
Q3 | $839K | Buy |
+3,630
| New | +$839K | 0.39% | 62 |
|